Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Johnson & Johnson (NYSE: JNJ) is one of the leading and most recognizable names in healthcare. It generates billions in revenue and profit every year and its products are used all over the world. It's a truly global organization that has achieved considerable success over the years.
It also pays a dividend that it has increased for decades, giving investors plenty of incentive to buy and hold the stock, simply collecting that recurring payout along the way.
In the past 10 years, the stock's total returns (which include dividends) have come in around 125%, creating significant value for shareholders. It has been a great investment, particularly for risk-averse investors who wanted a stock they could just buy and forget about.
Source Fool.com
